Literature DB >> 31701240

Contemporary Approach to Locally Advanced Oral Cavity Squamous Cell Carcinoma.

Christopher M K L Yao1, Edward I Chang2, Stephen Y Lai3.   

Abstract

PURPOSE OF REVIEW: Surgical management of locally advanced oral cavity squamous cell carcinomas (OCSCC) has long been recognized as a primary treatment modality. Technological advances have led to significant improvements in our surgical approach, from improvement in the visualization of tumors to more efficient and precise reconstruction. Here, we review the latest technological advances in surgical extirpation and reconstruction of locally advanced OCSCCs. RECENT
FINDINGS: The focus of technological innovation in surgical extirpation has been on improving visualization, with the use of intraoperative ultrasound for margin delineation, intraoperative navigation, narrow-band imaging, and the use of fluorescence. Though early, these are promising steps to ensuring complete resection of the cancer. Advances in reconstruction have been centered on the incorporation of computer assisted design, manufacturing, and virtual surgical planning, allowing for more complex three-dimensional defects to be expeditiously reconstructed. As these technologies are still under development, their impact on oncologic outcomes are not yet robustly defined; however, as technology continues to advance and become more widely available, new technologies will undoubtedly become integrated into enhancing surgical precision and planning.

Entities:  

Keywords:  Advanced oral cavity carcinoma; Image-guided surgery; Oral cavity reconstruction; Technology; Tumor margins; Virtual surgical planning

Year:  2019        PMID: 31701240     DOI: 10.1007/s11912-019-0845-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  69 in total

1.  Cut margins and disease control in oral cancers.

Authors:  S R Priya; A K D'Cruz; P S Pai
Journal:  J Cancer Res Ther       Date:  2012 Jan-Mar       Impact factor: 1.805

2.  Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.

Authors:  Eben L Rosenthal; Jason M Warram; Esther de Boer; Thomas K Chung; Melissa L Korb; Margie Brandwein-Gensler; Theresa V Strong; Cecelia E Schmalbach; Anthony B Morlandt; Garima Agarwal; Yolanda E Hartman; William R Carroll; Joshua S Richman; Lisa K Clemons; Lisle M Nabell; Kurt R Zinn
Journal:  Clin Cancer Res       Date:  2015-04-22       Impact factor: 12.531

3.  Osseointegrated implant-based dental rehabilitation in head and neck reconstruction patients.

Authors:  Sydney Ch'ng; Roman J Skoracki; Jesse C Selber; Peirong Yu; Jack W Martin; Theresa M Hofstede; Mark S Chambers; Jun Liu; Matthew M Hanasono
Journal:  Head Neck       Date:  2015-06-29       Impact factor: 3.147

4.  Intraoperative image guidance in transoral robotic surgery: A pilot study.

Authors:  Andrew K Ma; Michael Daly; Jimmy Qiu; Harley H L Chan; David P Goldstein; Jonathan C Irish; John R de Almeida
Journal:  Head Neck       Date:  2017-07-28       Impact factor: 3.147

5.  Changing prognosis of oral cancer: An analysis of survival and treatment between 1973 and 2014.

Authors:  Shayan Cheraghlou; Amy Schettino; Cheryl K Zogg; Benjamin L Judson
Journal:  Laryngoscope       Date:  2018-09-07       Impact factor: 3.325

6.  Intraoperative navigation in complex head and neck resections: indications and limits.

Authors:  S Catanzaro; C Copelli; A Manfuso; K Tewfik; N Pederneschi; L Cassano; R Cocchi
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-09-22       Impact factor: 2.924

7.  Updates in Head and Neck Reconstruction.

Authors:  Rene D Largo; Patrick B Garvey
Journal:  Plast Reconstr Surg       Date:  2018-02       Impact factor: 4.730

Review 8.  Systematic review of primary osseointegrated dental implants in head and neck oncology.

Authors:  A J Barber; C J Butterworth; S N Rogers
Journal:  Br J Oral Maxillofac Surg       Date:  2010-01-15       Impact factor: 1.651

9.  Determination of deep surgical margin based on anatomical architecture for local control of squamous cell carcinoma of the buccal mucosa.

Authors:  Yoshihide Ota; Takayuki Aoki; Kazunari Karakida; Mitsunobu Otsuru; Hirotaka Kurabayashi; Masashi Sasaki; Naoya Nakamura; Hiroshi Kajiwara
Journal:  Oral Oncol       Date:  2008-11-20       Impact factor: 5.337

10.  Multiplexed Molecular Imaging of Biomarker-Targeted SERS Nanoparticles on Fresh Tissue Specimens with Channel-Compressed Spectrometry.

Authors:  Soyoung Kang; Yu Wang; Nicholas P Reder; Jonathan T C Liu
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

View more
  8 in total

1.  Demographic and pathologic factor regression to a growth rate model of p16-negative oral cavity squamous cell carcinoma.

Authors:  Jacob G J Wihlidal; Keng Yeow Tay; S Danielle MacNeil; Anthony C Nichols; Kevin Fung; John H J Yoo; Adrian I Mendez
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-08-16

2.  Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.

Authors:  Yunfei Lu; Jing Lin; Meng Duan; Ying Rui; Hao Zheng; Liting Zhu; Xuanyu Zhu; Jingchen Wei
Journal:  Anal Cell Pathol (Amst)       Date:  2021-12-08       Impact factor: 2.916

3.  Advanced Lung Cancer Inflammation Index Predicts Survival Outcomes of Patients With Oral Cavity Cancer Following Curative Surgery.

Authors:  Yao-Te Tsai; Cheng-Ming Hsu; Geng-He Chang; Ming-Shao Tsai; Yi-Chan Lee; Ethan I Huang; Chia-Hsuan Lai; Ku-Hao Fang
Journal:  Front Oncol       Date:  2021-09-30       Impact factor: 6.244

4.  Long non-coding RNA HCG22 inhibits the proliferation, invasion and migration of oral squamous cell carcinoma cells by downregulating miR-425-5p expression.

Authors:  Yating Fu; Ying Liu; Aheli Nasiroula; Qichao Wang; Xinhua Cao
Journal:  Exp Ther Med       Date:  2022-01-28       Impact factor: 2.447

5.  CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.

Authors:  Liang Rong; Bo Chen; Ke Liu; Bingyao Liu; Xinyao He; Juan Liu; Junxia Li; Maodian He; Lei Zhu; Ke Liu; Xiaolei Shi; Yi Shuai; Lei Jin
Journal:  J Transl Med       Date:  2022-04-01       Impact factor: 8.440

6.  Risk Stratification in Oral Cancer: A Novel Approach.

Authors:  Irene Wen-Hui Tu; Nicholas Brian Shannon; Krishnakumar Thankappan; Deepak Balasubramanian; Vijay Pillai; Vivek Shetty; Vidyabhushan Rangappa; Naveen Hedne Chandrasekhar; Vikram Kekatpure; Moni Abraham Kuriakose; Arvind Krishnamurthy; Arun Mitra; Arun Pattatheyil; Prateek Jain; Subramania Iyer; Narayana Subramaniam; N Gopalakrishna Iyer
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

7.  Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.

Authors:  Ming Li; Feng Gao; Xinfang Yu; Qing Zhao; Li Zhou; Wenbin Liu; Wei Li
Journal:  J Exp Clin Cancer Res       Date:  2020-05-14

8.  miR-29a-3p enhances the radiosensitivity of oral squamous cell carcinoma cells by inhibiting ADAM12.

Authors:  Cuihong Jiang; Feng Liu; Shuai Xiao; Lili He; Wenqiong Wu; Qi Zhao
Journal:  Eur J Histochem       Date:  2021-09-27       Impact factor: 3.188

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.